tiprankstipranks
Trending News
More News >
Ascletis Pharma, Inc. (HK:1672)
:1672
Hong Kong Market

Ascletis Pharma, Inc. (1672) Similar Stocks

Compare
8 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Ascletis Pharma, Inc.
HK$14.52
HK$14.50B
-50.95
569.12%
0 Buy
1 Hold
0 Sell
Hold
Lepu Biopharma Co. Ltd. Class H
HK$5.34
HK$9.93B
-47.42
107.78%
1 Buy
0 Hold
0 Sell
Moderate Buy
CARsgen Therapeutics Holdings Ltd.
HK$15.60
HK$9.02B
-15.69
61.66%
0 Buy
0 Hold
0 Sell
Moderate Buy
Jiangsu Recbio Technology Co., Ltd. Class H
HK$5.49
HK$2.63B
-3.73
-33.70%
Shanghai Henlius Biotech, Inc. Class H
HK$64.80
HK$35.22B
39.57
191.24%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$8.95
HK$5.57B
144.82
1.47%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:1672
Ascletis Pharma, Inc.
14.52
12.35
569.12%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.34
2.69
101.51%
HK:2171
CARsgen Therapeutics Holdings Ltd.
15.60
5.95
61.66%
HK:2179
Jiangsu Recbio Technology Co., Ltd. Class H
5.49
-2.79
-33.70%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
64.80
42.55
191.24%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
8.95
0.07
0.79%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts